“…The sensitivity of the two strains, HB-TS-YT-1 hyg and HB-TS-YT-1 hyg -V, to difenoconazole [Active ingredient (AI): 94.50%], prochloraz (AI: 98.00%), and pydiflumetofen (AI: 98.00%) was evaluated in vitro, as described in a previous study [41]. The PDA media were amended with difenoconazole, prochloraz, and pydiflumetofen to establish the final concentrations of 5.00, 1.00, 0.50, 0.10, and 0.05 µg/mL, 0.50, 0.10, 0.05, 0.01, and 0.005 µg/mL, and 1.00, 0.50, 0.10, 0.05, and 0.01 µg/mL, respectively.…”